| When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions ARM Bradbury, ND Trinklein, H Thie, IC Wilkinson, AK Tandon, ... MAbs 10 (4), 539-546, 2018 | 98 | 2018 |
| Many routes to an antibody heavy-chain CDR3: necessary, yet insufficient, for specific binding S D’Angelo, F Ferrara, L Naranjo, MF Erasmus, P Hraber, ARM Bradbury Frontiers in immunology 9, 336672, 2018 | 95 | 2018 |
| Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases F Ferrara, S Quaglia, I Caputo, C Esposito, M Lepretti, S Pastore, R Giorgi, ... Clinical & Experimental Immunology 159 (2), 217-223, 2010 | 88 | 2010 |
| Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker F Ferrara, LA Naranjo, S Kumar, T Gaiotto, H Mukundan, B Swanson, ... PloS one 7 (11), e49535, 2012 | 87 | 2012 |
| Looking for celiac disease: diagnostic accuracy of two rapid commercial assays G Nemec, A Ventura, M Stefano, G Di Leo, V Baldas, A Tommasini, ... Official journal of the American College of Gastroenterology| ACG 101 (7 …, 2006 | 83 | 2006 |
| Deep sequencing in library selection projects: what insight does it bring? J Glanville, S D’Angelo, TA Khan, ST Reddy, L Naranjo, F Ferrara, ... Current opinion in structural biology 33, 146-160, 2015 | 79 | 2015 |
| Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet T Not, F Ziberna, S Vatta, S Quaglia, S Martelossi, V Villanacci, R Marzari, ... Gut 60 (11), 1487-1493, 2011 | 68 | 2011 |
| Regulatory T-cell function is impaired in celiac disease M Granzotto, S Dal Bo, S Quaglia, A Tommasini, E Piscianz, E Valencic, ... Digestive diseases and sciences 54, 1513-1519, 2009 | 68 | 2009 |
| Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release H Hosoya, AS Dobroff, WHP Driessen, V Cristini, LM Brinker, FI Staquicini, ... Proceedings of the National Academy of Sciences 113 (7), 1877-1882, 2016 | 66 | 2016 |
| Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer FI Staquicini, MD Qian, A Salameh, AS Dobroff, JK Edwards, DF Cimino, ... Journal of Biological Chemistry 290 (12), 7345-7359, 2015 | 55 | 2015 |
| The antibody mining toolbox: an open source tool for the rapid analysis of antibody repertoires S D'Angelo, J Glanville, F Ferrara, L Naranjo, CD Gleasner, X Shen, ... MAbs 6 (1), 160-172, 2014 | 54 | 2014 |
| Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer F Ferrara, DI Staquicini, WHP Driessen, S D’Angelo, AS Dobroff, M Barry, ... Proceedings of the National Academy of Sciences 113 (45), 12786-12791, 2016 | 53 | 2016 |
| Recombinant renewable polyclonal antibodies F Ferrara, S D’Angelo, T Gaiotto, L Naranjo, H Tian, S Gräslund, ... MAbs 7 (1), 32-41, 2015 | 51 | 2015 |
| From deep sequencing to actual clones S D'Angelo, S Kumar, L Naranjo, F Ferrara, C Kiss, ARM Bradbury Protein Engineering, Design & Selection 27 (10), 301-307, 2014 | 49 | 2014 |
| Characterizing monoclonal antibody epitopes by filtered gene fragment phage display R Di Niro, F Ferrara, T Not, ARM Bradbury, F Chirdo, R Marzari, ... Biochemical Journal 388 (3), 889-894, 2005 | 47 | 2005 |
| Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes AS Dobroff, S D’Angelo, BL Eckhardt, F Ferrara, DI Staquicini, ... Proceedings of the National Academy of Sciences 113 (45), 12780-12785, 2016 | 36 | 2016 |
| Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates DI Staquicini, S D'Angelo, F Ferrara, K Karjalainen, G Sharma, TL Smith, ... The pharmacogenomics journal 18 (3), 436-443, 2018 | 29 | 2018 |
| Profiling celiac disease antibody repertoire S D'Angelo, F Mignone, C Deantonio, R Di Niro, R Bordoni, R Marzari, ... Clinical Immunology 148 (1), 99-109, 2013 | 29 | 2013 |
| Fluorescent labeling of antibody fragments using split GFP F Ferrara, P Listwan, GS Waldo, ARM Bradbury PLoS One 6 (10), e25727, 2011 | 27 | 2011 |
| Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries AAR Teixeira, MF Erasmus, S D’Angelo, L Naranjo, F Ferrara, ... MAbs 13 (1), 1980942, 2021 | 26 | 2021 |
Andrew BradburyLos Alamos National Laboratory and Specifica Inc.Verified email at lanl.gov
